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ABSTRACT
A 52-year-old woman is reported with atopic cough, 
in whom bronchoprovocation with Streptomyces albus
antigen induced cough and bronchoscopic biopsy
revealed eosinophilic tracheobronchitis. She was
admitted for the diagnosis and treatment of severe
non-productive cough. Although her induced sputum
contained 8% eosinophils of nucleated cells and
bronchoscopic biopsy specimens revealed eosinophil
infiltration in both tracheal and bronchial wall, she
did not have bronchial hyperresponsiveness to
methacholine or heightened bronchomotor tone.
Bronchodilator therapy was not effective for her
coughing. Her symptoms worsened on returning
home, suggesting the existence of some etiologic
agents in her house. Streptomyces albus was isolated
from her house. A high titer of anti-S. albus antibody
was detected in her serum and the bronchoprovo-
cation test with S. albus antigen was positive:
development of coughing 15 min later and decrease
in cough threshold to inhaled capsaicin 24 h later 
(3.9 m mol/L from 31.3 m mol/L prechallenge). This is
the first report on eosinophilic tracheobronchitis with
cough hypersensitivity caused by allergic reaction to
S. albus antigen.
Key words: atopic cough, capsaicin cough sensitivity,
chronic cough, cough hypersensitivity, eosinophilic
tracheobronchitis, Streptomyces albus.
INTRODUCTION
Cough is a common presenting symptom in general
practice and in the chest clinic. Patients presenting with
chronic non-productive cough resistant to antibiotics and
the usual antitussive agents are frequently introduced
to our clinic for diagnosis and treatment. It has been
established that cough can be the sole manifestation of
asthma, cough variant asthma,1 with bronchial hyper-
responsiveness, which is a fundamental feature of
bronchial asthma. The cough is relieved on the broncho-
dilator therapy. However, some patients have a
bronchodilator-resistant non-productive cough associ-
ated with global atopic tendency, in which the cough is
diminished by selective histamine H1-antagonists and/
or glucocorticosteroids.2–5 In such patients, non-specific
bronchial responsiveness is within normal limits2–4
and airway cough sensitivity to inhaled capsaicin is
heightened.3 Hypertonic saline-induced sputum contains
eosinophils4 and bronchoscopic biopsy shows eosinophil
infiltration in bronchial tissue.5 We have proposed that
the chronic bronchodilator-resistant non-productive cough
is associated with global atopic tendency and airway
cough hypersensitivity without non-specific bronchial
hyperresponsiveness, abbreviated as ‘atopic cough’,
a clinical entity for the pathologic cough.
We report here the first case of atopic cough caused by
allergic reaction to S. albus antigen, which was diag-
nosed by antigen inhalation challenge. In addition, we
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have shown that a histologic feature of atopic cough is
eosinophilic tracheobronchitis.
CLINICAL SUMMARY
A 52-year-old woman was admitted to our hospital on
9 September 1996, because of severe non-productive
cough with ticklish throat and chest wall pain and urinary
extravasation caused by the severe coughing for
2 months. Further questioning revealed that she had con-
sulted a physician and had been diagnosed as having
‘acute bronchitis’ in summer 1995. She was an office
worker and lived with her family in a 10-year-old wooden
house. She had never smoked and did not drink any
alcoholic beverages.
Physical examination revealed the following: tempera-
ture 36.5°C; blood pressure 140/88 mmHg; heart rate
66 beats/min. The conjunctivae were not anemic or
icteric. Cardiac examination was entirely within normal
limits. Auscultation of lungs revealed no rales. There was
no lymphadenopathy. The abdomen was benign and
without organomegaly. The extremities were intact for
neurologic examination.
The white blood cell count was 5300 /m L with a dif-
ferential of 64.9% segmented neutrophils, 24.9%
lymphocytes, 7.0% monocytes and 3.0% eosinophils.
The erythrocyte sedimentation rate was 12 mm/h. The 
C-reactive protein level was 0.11 mg/dL and the total IgE
level was 1 U/mL. Specific IgE antibodies were negative
for house dust 1, 2 and 6, Dermatophagoides pteronys-
sinus and D. farinae, Japanese cedar, ragweed, orchard
grass, Aspergillus and Candida antigens. Arterial blood
gas levels while breathing room air were PaO2 83.9
mmHg, PaCO2 44.3 mmHg and pH 7.40. The following
laboratory findings were normal or negative: urinalysis,
stools for ova and parasites, serum electrolytes, total
protein and albumin and mycobacterial and fungal cul-
tures of sputum. Differential cell analysis of sputum
induced by inhalation of hypertonic saline4 revealed mild
eosinophilia (8% of nucleated cells). The electrocardio-
gram showed normal sinus rhythm.
The chest radiograph and the chest computed tomo-
graphic (CT) scan on admission showed normal findings.
The pulmonary function test performed using a Collins
DS system, according to the standards of the American
Thoracic Society,6 revealed forced vital capacity (FVC)
2.51 L (97.7% of predicted value), forced expiratory
volume in 1 s (FEV1) 2.02 L (91.4% of predicted value),
FEV1/FVC ratio 80.5%, total lung capacity (TLC) 3.84 L
(96.5% of predicted value), respiratory volume (RV)
1.35 L (84.9% of predicted value), carbon monoxide dif-
fusing capacity (DLCO) 15.41 mL/min per mmHg (85.3%
of predicted value) and DLCO/alveolar ventilation (VA)
ratio 4.97 mL/min per mmHg per L (101.4% of predicted
value). To assess bronchial reversibility, spirometry was
carried out before and 30 min after an inhalation of
300 m g salbutamol sulfate following an intravenous
administration of 250 mg aminophylline. The broncho-
dilator therapy did not significantly increase FEV1 (from
2.15 to 2.23 L) or FVC (from 2.57 to 2.53 L), indicating
that the patient’s bronchomotor tone was not increased.
Bronchial responsiveness to methacholine was measured
according to the method of Cockcroft et al.7 The provoca-
tive concentration of methacholine required to cause a
20% fall from the baseline FEV1 (PC20) was 20 mg/mL.
Capsaicin cough threshold measured by our previously
reported method8,9 was 1.95 m mol/L, suggesting cough
hypersensitivity.
Transbronchoscopic bronchial biopsy (TBBB) specimens
obtained from a bifurcation of the right upper lobe
bronchus and truncus intermedicus showed mild infiltration
of eosinophils and lymphocytes in the edematous sub-
mucosal tissue (Fig. 1). Furthermore, we performed tracheal
biopsy to examine whether eosinophilic inflammation
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Fig. 1 Transbronchoscopic bronchial biopsy specimen showing
mild eosinophil and lymphocyte infiltration in the edematous
submucosal area. The biopsy specimen was obtained from a
bifurcation of the right upper lobe bronchus and truncus inter-
medicus.
existed in her trachea. The successfully obtained tiny
specimens demonstrated mild eosinophil infiltration in
the submucosal area of the trachea (Fig. 2). Broncho-
alveolar lavage fluid (BALF; total cells 7.9 · 10–6
cells/mL) recovered from the right S4 consisted of 
75.5% macrophages, 0% eosinophils, 0% neutrophils
and 24.5% lymphocytes.
These findings suggested that this case was broncho-
dilator-resistant cough associated with atopy (atopic
cough).2–5 Indeed, although bronchodilator therapy with
procaterol aerosol (60 m g/day) failed to relieve her cough,
a histamine H1-antagonist, terfenadine (120 mg/day),
and beclomethasone dipropionate (BDP) inhalation 
(600 m g/day) were effective.
Her coughing was worsened on returning home, sug-
gesting existence of some etiologic agents. From the
sterile Petri dishes containing Sabouraud’s agar medium
supplemented with antibiotics exposed for 10 min on the
floor of every room in the patient’s house with closed
windows, S. albus and Cladosporium sphaerospermum
were isolated in the living room.
For the preparation of antigenic solution, each fungus
was cultured on the medium (1% peptone, 2% glucose)
with 0.5% yeast extract for 20 days and dried by acetone.
Skin tests of the fungal antigens (polysaccharide) were
done by intradermal injection with 0.02 mL of the solu-
tions (1 mg/mL). The immediate-type skin reactions were
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Fig. 2 Transbronchoscopic tracheal biopsy specimen showing
mild eosinophil infiltration in the submucosal area.
Table 1 Allergologic findings
Test Streptomyces Cladosporium
albus sphaerospermum
Skin test
Immediate 0 · 0/5 · 3 0 · 0/5 · 3
6 h 0 · 0/8 · 4 0 · 0/11 · 9
24 h 0 · 0/13 · 13 0 · 0/0 · 0
48 h 0 · 0/0 · 0 0 · 0/0 · 0
Precipitating antibody · 2 –
Skin test results are given in mm.
Table 2 Clinical and laboratory findings in the inhalation challenge test with Streptomyces albus and Cladosporium sphaeros-
permum antigens
Pre 20 min 6 h 24 h
S. albus
Cough None Mild Mild None
BT (°C) 36.7 36.9 36.7 36.9
CRP (mg/dL) 0.06 0.07
WBC (m L) 4300000. 4700.000
Eos. (%) 5.1 3.5
DLCO (%) 85.3 88.9
Cough threshhold (m mol/L) 31.2 3.90
C. sphaerospermum 
Cough None None None None
BT (°C) 36.6 36.8 36.7 36.7
CRP (mg/dL) 0.1 0.12
WBC (m L) 5200000. 3900.000
Eos. (%) 3.2 4.3
DLCO (%) 73.1 84.9
Cough threshhold (m mol/L) 62.5 1250.0
BT, body temperature; CRP, C-reactive protein; WBC, white blood cells; Eos., eosinophils; DLCO, carbon monoxide diffusing capacity.
negative and late-type skin reactions were weakly positive
for both S. albus and C. sphaerospernum . The serum
antifungus antibody titers referred to IgG based on the
Ouchterlony method were · 2 for S. albus and negative
for C. sphaerospernum (Table 1).
The bronchoprovocation test with C. sphaerospernum
antigen (2 mL of culture-filtrate antigen (1 mg/mL)) per-
formed under the informed consent was negative and
that with S. albus was judged positive. Although none of
the parameters examined for hypersensitivity pneumonitis
changed, the patient developed cough attack with a
significant increase in airway cough sensitivity, assessed
by the capsaicin provocation cough test, during the next
24 h. The antigen-induced symptoms and signs had dis-
appeared by 24 h after the challenge test (Table 2).
Based on these results, we advised the patient to
cleanse the entire house, especially the living room con-
taminated with S. albus, and neither S. albus nor 
C. sphaerospernum were isolated in the room after
cleaning.
Prednisolone (20 mg/day) was tapered to zero on 21st
day, when her symptoms subsided.
DISCUSSION
Although sputum eosinophilia is characteristic of
bronchial asthma and eosinophilic pneumonia,10 it is
also seen in drug-induced eosinophilic bronchitis,11
eosinophilic bronchitis without asthma described by
Gibson et al.12 and bronchodilator-resistant non-produc-
tive cough associated with atopy (atopic cough).2–5
In our case, absence of active pulmonary infiltrates
on chest radiographic films and chest CT and normal
diffusing capacity showed a lack of definite alveolitis,
indicating that her sputum eosinophilia might have
resulted from eosinophilic bronchitis but not from
eosinophilic pneumonia. Although the patient’s sputum
contained 8% eosinophils, she did not have increased
bronchial responsiveness to methacholine or heightened
bronchomotor tone, the fundamental features of bron-
chial asthma. Furthermore, bronchodilator therapy was
not effective for her coughing. We tried tracheal and
bronchial biopsies in this case and successfully obtained
specimens that revealed eosinophilic tracheobronchitis.
These findings supported the diagnosis of eosinophilic
tracheobronchitis with cough hypersensitivity without
bronchoconstriction.
In the eosinophilic bronchitis without asthma described
by Gibson and associates,12,13 the cough is productive
and eosinophils are increased in BALF. In contrast, the
cough is non-productive and BALF eosinophilia is absent
in atopic cough,5 indicating that atopic cough is different
from eosinophilic bronchitis without asthma. Thus, we
have proposed atopic cough as a new clinical entity.5 The
term ‘atopy’ is generally recognized to be the hereditary
productivity of IgE antibody and also means the factor
that may develop atopic diseases in future from a global
aspect. Based on our series of clinical studies on chronic
cough, the clinical features of atopic cough are consid-
ered to be: (i) chronic non-productive cough with a
‘tickle’ in the throat lasting for more than 8 weeks; (ii)
absence of wheeze, dyspnea, hemoptysis or pleurisy and
no adventitious lung sounds on examination; (iii) pres-
ence of one or more of the global atopic findings: past
history and/or complication of allergic disease (except for
bronchial asthma), family history of allergic diseases,
peripheral blood eosinophilia, elevated total IgE level 
in serum, positive specific IgE antibody to common
inhalants or positive allergen skin test; (iv) existence of
eosinophils in sputum, hypertonic saline-induced sputum
and/or biopsied bronchial wall; (v) normal FEV1, FVC,
and FEV1/FVC ratio; (vi) no bronchial reversibility defined
as less than 5% increase in FEV1 after inhalation of 
300 m g salbutamol following aminophylline (250 mg)
injection; (vii) no bronchial hyperresponsiveness; (viii)
airway cough hypersensitivity; and (ix) complete relief
from the cough on treatment with histamine H1-antag-
onists and/or corticosteroid therapy. In addition, the
tracheal biopsy findings seen in this case may add
eosinophil infiltration in the trachea to this list.
The remarkable characteristic of our case was the
recurrence of coughing after returning home,14 suggest-
ing the existence of some etiologic agents in the patient’s
house. Recently, because the acute form of eosinophilic
pneumonia, suggesting a hypersensitivity reaction, had
been described,15,16 we conducted an environmental
survey of her house.17
The conclusion that the eosinophilic tracheobronchitis
with cough hypersensitivity in the present case was induced
by S. albus antigen was based on the following evidence:
(i) S. albus was isolated from the patient’s house; (ii) anti-S.
albus IgG antibody was detected in her serum; and (iii) a
bronchoprovocation test with S. albus antigen, assessed by
appearance of coughing and measuring of cough sensitiv-
ity to inhaled capsaicin, was positive.
Based on these findings, the patient was diagnosed
with atopic cough caused by S. albus antigen and suc-
cessfully treated by cessation of exposure to the antigen.
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Although ubiquitous in soil, Streptomyces spp. are
rarely associated with human diseases. In India, myce-
tomas of the lower extremities are known to occur18 and
hypersensitivity pneumonitis, caused by S. albus, has
been reported by Steven et al.19
This is the first report of atopic cough caused by a
hypersensitivity to S. albus antigen. The discovery of
causative antigens is recommended through environ-
mental survey and antigen bronchoprovocation in
atopy-based chronic cough.
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